Anniversary Timeline
25th Years of Innovation

2014: First Industrial Fermentation-derived perfume ingredient Clearwood®
Nominated by: Scienceindustries Switzerland Organisation in nomination: Firmenich Terpenes are complex natural compounds and important raw materials for the fragrance & flavour and the pharmaceutical industries...Read More
2014: Checkpoint inhibitor innovation as key part of cancer immunotherapy
Nominated by: UK BioIndustry Association Organisation in nomination: LifeArc (From 2004) US Biotech company Organon’s scientists focused on the discovery of antibodies as therapeutics and..Read More
2013: First approved cancer treatment using antibody glycosylation (glycoMAb) – Gazyvaro
Nominated by: Swiss Biotech Association Organisations in nomination: Glycart Biotechnology (now Roche Glycart AG) Pioneer in antibody glycosylation (glycoMAb) technology increasing immune-mediated killing of cancer cells..Read More
2012: Collaborative patient partnership delivers first treatment approved in Europe for genetic disease, Alkaptonuria (AKU)
Nominated by: Sobi, Swedish Orphan Biovitrum Organisations in nomination: DevelopAKUre Consortium AKU is a serious, multi-system disorder affecting approximately 1 in 250,000 people, first described as..Read More
2007: Landmark European publication behind ‘Knowledge Based Bioeconomy’ in Europe
Nominated by: BIO Deutschland Under the German Presidency of the Council of the European Union, 42 experts from academia and industry across 13 countries were invited..Read More
2007: First production of spider silk through biotechnology
Nominated by: BIO Deutschland Organisation in nomination: AMSilk Spider silk has long been hailed for its properties, the ultimate biomaterial, however production from spiders directly on..Read More
BIOTECH NEWSLETTER
Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!
Subscribe
BIOTECH NEWSLETTER
Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!
Subscribe